- Home
- RMBS vs KZR Comparison
RMBS vs KZR Comparison
Compare RMBS & KZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RMBS | KZR |
|---|---|---|
| Founded | 1990 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.7B | 54.2M |
| IPO Year | 1997 | 2018 |
Fundamental Metrics
Financial Performance| Metric | RMBS | KZR |
|---|---|---|
| Price | $127.87 | $7.34 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 7 | 4 |
| Target Price | ★ $108.17 | $6.00 |
| AVG Volume (30 Days) | ★ 1.8M | 123.4K |
| Earning Date | 04-27-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 27.88 | ★ 33.33 |
| EPS | ★ 2.11 | N/A |
| Revenue | ★ $707,630,000.00 | N/A |
| Revenue This Year | $16.01 | N/A |
| Revenue Next Year | $16.23 | N/A |
| P/E Ratio | $56.85 | ★ N/A |
| Revenue Growth | ★ 27.13 | N/A |
| 52 Week Low | $43.21 | $3.53 |
| 52 Week High | $135.75 | $7.55 |
Technical Indicators
Market Signals| Indicator | RMBS | KZR |
|---|---|---|
| Relative Strength Index (RSI) | 73.97 | 59.24 |
| Support Level | $90.31 | $7.32 |
| Resistance Level | $128.23 | $7.35 |
| Average True Range (ATR) | 6.31 | 0.13 |
| MACD | 3.74 | 0.00 |
| Stochastic Oscillator | 98.81 | 26.67 |
Price Performance
Historical ComparisonAbout RMBS Rambus Inc.
Rambus Inc is a semiconductor company providing chips and silicon IP for data-intensive computing systems, focusing on data center and artificial intelligence (AI) infrastructure. The company is at the forefront of enabling the next era of AI-driven computing, addressing challenges of signal and power integrity at increasingly extreme data rates across the data center, edge, and client markets. It offers high-performance memory subsystems, with a balanced and diverse portfolio of products, IP, and patents that maximize performance and security in computationally intensive systems. The company operates in South Korea, Singapore, the United States, and other countries, with the majority of its revenue coming from South Korea.
About KZR Kezar Life Sciences Inc.
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.